Genomic and Clinical Characterization of IMP-1-Producing Multidrug-Resistant Acinetobacter bereziniae Isolates from Bloodstream Infections in a Brazilian Tertiary Hospital

Microb Drug Resist. 2020 Nov;26(11):1399-1404. doi: 10.1089/mdr.2019.0210. Epub 2020 Mar 9.

Abstract

Acinetobacter baumannii is the main species of the Acinetobacter genus; however, non-baumannii Acinetobacter (NBA) species causing infections have been described for the past years, as well as antimicrobial resistance. In this study, we describe the occurrence of two multidrug-resistant (MDR) IMP-1-producing Acinetobacter bereziniae isolates recovered from bloodstream infections in different patients but in the same intensive care unit among 134 carbapenem-resistant Acinetobacter screened. Antimicrobial susceptibility testing revealed resistance to carbapenems, extended spectrum, and antipseudomonad cephalosporins, amikacin, and trimethoprim-sulfamethoxazole. Both A. bereziniae isolates shared the same ApaI-pulsed-field gel electrophoresis (PFGE) pattern. Whole-genome sequencing of both isolates revealed that blaIMP-1 was embedded into an In86 Class I integron carrying also sul1, aac(6')-31, and aadA genes. A new sequence type (ST1309 Pasteur) was deposited. The virulence genes lpxC and ompA, seen in A. baumannii, were detected in the A. bereziniae strains. Recognition of A. bereziniae causing invasive MDR infection underscores the role of NBA species as human pathogens especially in at-risk patients.

Keywords: Acinetobacter bereziniae; IMP-1; Ion Torrent; next-generation sequencing; whole genome sequencing.

MeSH terms

  • Acinetobacter / drug effects
  • Acinetobacter / genetics*
  • Acinetobacter / isolation & purification*
  • Acinetobacter Infections / drug therapy
  • Acinetobacter Infections / microbiology
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics*
  • Bacterial Proteins / metabolism*
  • Brazil
  • Carbapenems / pharmacology
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Genomics / methods
  • Humans
  • Integrons / genetics
  • Microbial Sensitivity Tests / methods
  • Sepsis / drug therapy
  • Sepsis / microbiology*
  • Tertiary Care Centers
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • beta-lactamase IMP-1
  • beta-Lactamases

Supplementary concepts

  • Acinetobacter bereziniae